These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 12675853)

  • 1. Endothelial-derived vasoactive mediators in polycystic kidney disease.
    Al-Nimri MA; Komers R; Oyama TT; Subramanya AR; Lindsley JN; Anderson S
    Kidney Int; 2003 May; 63(5):1776-84. PubMed ID: 12675853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-induced microvascular dysfunction in the hydronephrotic kidney: role of nitric oxide.
    De Vriese AS; Stoenoiu MS; Elger M; Devuyst O; Vanholder R; Kriz W; Lameire NH
    Kidney Int; 2001 Jul; 60(1):202-10. PubMed ID: 11422752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender hormones and the progression of experimental polycystic kidney disease.
    Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
    Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease.
    Wang D; Iversen J; Wilcox CS; Strandgaard S
    Kidney Int; 2003 Oct; 64(4):1381-8. PubMed ID: 12969157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats.
    Schwartz D; Mendonca M; Schwartz I; Xia Y; Satriano J; Wilson CB; Blantz RC
    J Clin Invest; 1997 Jul; 100(2):439-48. PubMed ID: 9218522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the renal nitric oxide (NO) system: dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition.
    Reckelhoff JF; Hennington BS; Moore AG; Blanchard EJ; Cameron J
    Am J Hypertens; 1998 Jan; 11(1 Pt 1):97-104. PubMed ID: 9504456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F; Iversen BM; Chatziantoniou C
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1170-7. PubMed ID: 20219827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.
    Dautzenberg M; Keilhoff G; Just A
    J Physiol; 2011 Oct; 589(Pt 19):4731-44. PubMed ID: 21825026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats.
    Wang D; Braendstrup O; Larsen S; Horn T; Strandgaard S
    APMIS; 2004 Jun; 112(6):358-68. PubMed ID: 15511273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
    Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
    Schwartz D; Schwartz IF; Blantz RC
    J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
    Hsu YH; Hsu BG; Chen HI
    Chin J Physiol; 2007 Dec; 50(6):283-93. PubMed ID: 18442011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide.
    Schneider MP; Ge Y; Pollock DM; Pollock JS; Kohan DE
    Hypertension; 2008 Jun; 51(6):1605-10. PubMed ID: 18391099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic shock-induced vascular hyporeactivity in the rat: relationship to gene expression of nitric oxide synthase, endothelin-1, and select cytokines in corresponding organs.
    Liu LM; Dubick MA
    J Surg Res; 2005 May; 125(2):128-36. PubMed ID: 15854664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
    de la Torre JC; Aliev G
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):663-72. PubMed ID: 15703700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal dysfunction after chronic blockade of nitric oxide synthesis.
    Cachofeiro V; Fortepiani LA; Navarro-Cid J; Lahera V; García-Estañ J
    Antioxid Redox Signal; 2002 Dec; 4(6):885-91. PubMed ID: 12573137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion.
    Beierwaltes WH
    Am J Physiol Renal Physiol; 2002 Jul; 283(1):F68-72. PubMed ID: 12060588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.